Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

Emerson Electric Co. (NYSE: EMR) – worth at $111?

Emerson Electric Co. (NYSE: EMR) is under scrutiny today. Its stock has surged by 24% in recent months on the NYSE, nearing its 52-week peak. This indicates that any shifts in the company’s prospects may already be reflected in its stock price. Yet, is there still room for a good deal? Let’s delve into Emerson Electric’s valuation and future outlook to gauge potential bargain opportunities.

Assessing Emerson Electric’s Value
Our valuation model suggests the stock is currently reasonably priced, sitting approximately 8.2% below its intrinsic value. If you subscribe to the belief that the company’s true value stands at $121.19, there might not be much upside beyond its current price. However, the stock’s high beta suggests that in bearish markets, its price could drop more steeply than the broader market, presenting a favorable entry point.

Prospects for Growth
Looking ahead, future growth prospects are crucial, especially for investors seeking portfolio expansion. Investing in a strong company at a discounted rate is usually wise. Emerson Electric anticipates a robust 45% profit growth in the coming years, indicating potential for increased cash flow and higher stock valuation.

Implications for Investors
For current shareholders, it appears that EMR’s positive outlook is already factored into its fair value. However, other factors like the company’s financial stability warrant consideration. For potential investors, while now might not be the optimal time to buy given the fair valuation, the promising outlook suggests delving deeper into factors such as the strength of the company’s balance sheet to capitalize on future price fluctuations.